Femara (chemical name: letrozole) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat:
Earlier this summer, the National Institutes of Health decided not to fund a breast cancer prevention trial to test Letrozole (Femara), an... Read more »
I wrote about CYP2D6, which refers to a gene that codes for a biologic molecule involved in the breakdown of tamoxifen, about a year ago. ... Read more »
It takes a lot of reading to keep current on the latest scientific developments in breast cancer treatment and diagnosis. Here’s a digest... Read more »
Source: Breastcancer.org
Brand name: Femara Chemical name: Letrozole Class: Aromatase inhibitor hormonal therapy. Aromasin and Arimidex are other aromatase inhibitors. How it... Read more »
A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the... Read more »
Source: First DataBank
Generic Name: LETROZOLE - ORAL Pronounced: (LET-tro-zole) Uses This medication is used to treat certain types of breast cancer (such as... Read more »
Source: Breastcancer.org
Tykerb (chemical name: lapatinib) has been approved by the U.S. Food and Drug Administration (FDA): to be given in combination with Xeloda (chemical... Read more »
Source: Breastcancer.org
Standard systemic (whole-body) treatments include hormonal therapy, chemotherapy, and targeted therapy (for example, Herceptin (chemical name:... Read more »